SCOTTSDALE, Ariz., March 10 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, will be presenting on Wednesday, March 17, 2010, at the Roth Capital Partners 22nd Annual OC Growth Stock Conference.
The Company will be presenting at 11:00 a.m. PT. To listen to the live presentation, please visit www.matrixxinc.com and click on Events & Presentations. A replay of the presentation will be archived at the same web site address for 30 days.
About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam® products in the cough and cold category. The Company markets Zicam brand pharmaceuticals, including Zicam Cold Remedy in multiple oral delivery forms; Zicam Allergy and Congestion Relief products; as well as Zicam Cough and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to www.Zicam.com. To find out more about Matrixx Initiatives, Inc. ( MTXX), visit our website at www.matrixxinc.com. For additional information, contact Bill Barba, Treasurer, 602-385-8881. Matrixx is located at 8515 E. Anderson Dr., Scottsdale, Arizona 85255.
SOURCE Matrixx Initiatives, Inc.Back to top
|SOURCE Matrixx Initiatives, Inc.|
Copyright©2010 PR Newswire.
All rights reserved